1 Min Read
Dec 14 (Reuters) - Vericel Corp:
* FDA approves MACI for the treatment of symptomatic cartilage defects of the knee in adults Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.